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Abstract
Background: The aim of this study was to evaluate the contribution of bronchial epithelium to
airway inflammation, with focus on mRNA and protein expression of cytokines of innate immunity
IL-6, IL-10 and TNF-α, in horses with Recurrent Airway Obstruction (RAO) during exacerbation
and in remission.
Results:  Despite marked clinical and physiologic alterations between exacerbation and after
remission in the RAO horses no differences were detected in either cytokine mRNA or protein
levels. Moreover, the expression of investigated cytokines in RAO horses on pasture did not differ
from controls.
In comparing real-time PCR analysis to results of immunohistochemistry only IL-10 mRNA and
protein levels in RAO horses on pasture were significantly correlated (rs = 0.893, p = 0.007).
Curiously, in controls examined on pasture the TNF-α protein level was positively correlated to
IL-10 mRNA expression (rs = 0.967, p = 0.007) and negatively correlated to IL-6 mRNA expression
(rs = -0.971, p = 0.001).
Conclusion:  Given the complementary relationship of assessing cytokines directly by
immunohistochemistry, or indirectly by PCR to mRNA, the lack of significant changes in either
mRNA or protein levels of IL-6, IL-10 or TNF-α mRNA in RAO horses in exacerbation suggests
that these particular cytokines in bronchial tissue may not play a substantive role in the active
inflammation of this disease. To support this contention further studies examining time dependency
of expression of IL-6, IL-10 or TNF-α are needed, as is expansion of the range of cytokines to
include other key regulators of airway inflammation.
Published: 23 February 2008
BMC Veterinary Research 2008, 4:8 doi:10.1186/1746-6148-4-8
Received: 6 September 2007
Accepted: 23 February 2008
This article is available from: http://www.biomedcentral.com/1746-6148/4/8
© 2008 Riihimäki et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Veterinary Research 2008, 4:8 http://www.biomedcentral.com/1746-6148/4/8
Page 2 of 7
(page number not for citation purposes)
Background
Bronchial epithelium acts not only as physical barrier but
also is a key factor of remodelling and secretion of inflam-
mation mediators in airways [1-4]. In addition to sam-
pling methods such as bronchoalveolar lavage (BAL) and
induced sputum, endobronchial biopsies have been used
as a key research tool over the last decade to study the
importance of bronchial epithelium in inflammatory dis-
eases and define disease progression in asthma and COPD
in humans [1,5-7], and evaluate the effects of different
drug treatments and environmental effects on bronchial
epithelium [8,9]. Besides identifying morphological
changes, examination of bronchial tissue can provide
information on mRNA expression and subsequent levels
of translated inflammatory mediators directly within the
tissue, both by resident cells and infiltrating inflammatory
cells using immunohistochemistry (IHC) [10-12].
Horses are commonly affected by the disease "Recurrent
Airway Obstruction (RAO)", which has many similarities
with asthma in people. Inflammatory changes in the air-
ways of horses with RAO have been studied predomi-
nately on the basis of cell samples collected by BAL, or less
commonly, by analysis of other respiratory tract samples,
such as bronchial brushing, tracheal lavage, exhaled
breath condensate, and even lung tissue samples [13-19].
Most of our current understanding about the mechanism
of inflammation and involvement of various regulatory or
effector cytokines in the airways of horses with RAO has
been derived from samples obtained by BAL. Apart from
recent work of Ainsworth et al [14], similar assessment of
bronchial tissues or direct identification of tissue cytokine
levels by immunohistochemistry, which has been invalu-
able in human respiratory research, remains poorly inves-
tigated in horses.
The aim of this study was to evaluate the contribution of
bronchial epithelium to airway inflammation in horses
with RAO during exacerbation and in remission, with ini-
tial focus on relative cytokine mRNA and protein expres-
sion of cytokines IL-6, IL-10 and TNF-α, that are involved
in innate non-specific immunity. The differences in
mRNA levels measured by quantitative real-time PCR
were compared with the corresponding protein levels in
epithelial tissue measured by IHC. The epithelial cytokine
levels in RAO horses during remission were also com-
pared against samples from healthy controls on pasture.
Results
Clinical examination and pulmonary function test
There was no statistical difference in age and body weight
in principal and control animals. The clinical score of
RAO horses on pasture was statistically lower than during
exacerbation (median ± SD, 7.00 ± 0.90 versus 3.00 ±
0.69, p = 0.02), but did not differ from control horses on
pasture (3.00 ± 0.69 RAO versus 2.00 ± 0.00 pasture con-
trols, p = 0.10). The RAO horses showed a significant
worsening of pulmonary function during exacerbation as
a response to provocation with mouldy hay, characterised
by significant increase in ΔPplmax (41.80 ± 17.27 cmH20
versus 9.70 ± 1.67 cmH20, p = 0.02) and RL (2.96 ± 0.76
cmH20/L/s versus 0.08 ± 0.02 cmH20/L/s, p = 0.02). Dur-
ing respiratory exacerbation in RAO horses, there was also
a significant decrease in Cdyn after removing one outlier
(0.21 ± 0.33 L/cmH20, versus 1.53 ± 0.51 L/cmH20 p =
0.036). During pasture the lung function improved in
RAO horses, but remained significantly different when
compared to healthy controls which had ΔPplmax of 5.89
± 1.87 cmH20, RL of 0.44 ± 0.12 cm H20/L/s and Cdyn of
1.54 ± 0.47 L/cmH20.
BAL cytology
The total cell count, percentage of neutrophils and total
number of neutrophils in BAL was statistically higher (p =
0.02) in RAO horses post provocation compared to sam-
ples taken during remission on pasture (neutrophil per-
centage, 48.00 ± 13.31 versus 11.00 ± 10.66). During the
pasture remission there was no statistical difference in
BAL neutrophil percentage in RAO horses compared to
controls (11.00 ± 10.66 versus 9.60 ± 6.82). Neither the
percentage of neutrophils nor absolute number of neu-
trophils correlated with levels of investigated cytokine
mRNA or protein expression. For the remaining cell types
the percentage of macrophages showed a negative correla-
tion with TNF-α mRNA expression in RAO horses during
pasture (rs = -0.893, p = 0.007) but the biological rele-
vance of this was of questionable significance.
Immunohistochemistry of endobronchial biopsies
While there was a tendency for bronchial epithelial levels
of IL-6 and TNF-α in RAO horses to increase during crisis
the differences did not reach statistical significance (Table
1, Figure 1). Expression of investigated cytokines in RAO
horses and controls on pasture did not differ, nor was any
correlation found between IHC expression of different
cytokines within individual horses.
Real-time PCR
The differences in cytokine mRNA levels from samples
during crisis and on pasture are shown in Figure 2. In
comparing RAO horses in crisis versus remission the only
significant alteration in endobronchial tissue cytokine
regulation was a 1.1 (median) fold decrease in TNF-α
mRNA when in crisis (p = 0.035). The mRNA levels of
investigated cytokines did not correlate with each other.
Differences in expression of investigated cytokine mRNA
in RAO horses and controls on pasture were not detected.BMC Veterinary Research 2008, 4:8 http://www.biomedcentral.com/1746-6148/4/8
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Immunohistochemistry versus real-time PCR
IL-10 mRNA levels in RAO horses on pasture was signifi-
cantly correlated with cytokine expression measured by
IHC (rs = 0.893, p = 0.007) whereas IL-6 and TNF-α
mRNA showed no correlation to their corresponding
cytokines on IHC. Curiously, in controls examined on
pasture, the TNF-α expression measured by IHC was pos-
itively correlated to IL-10 mRNA levels (rs = 0.967, p =
0.007) and negatively correlated to IL-6 mRNA levels (rs =
-0.971, p = 0.001). In controls there was no correlation
between investigated cytokines when comparing real-time
PCR analysis to results of immunohistochemistry.
Discussion
The horses in our study showed changes in pulmonary
function and clinical scores that confirmed a period of res-
piratory crisis with neutrophilic inflammation and airway
obstruction and also a period of remission. Surprisingly,
we were unable to detect significant differences in either
mRNA or protein expression in investigated cytokines in
endobronchial tissue between provocation and remis-
sion. The only statistically significant finding was a small
(1.1-fold down-regulation of TNF-α mRNA in endobron-
chial biopsies in RAO horses after provocation). However,
given the extreme sensitivity of real time-PCR methodol-
ogy this difference was unlikely of clinical relevance.
Earlier studies report conflicting results regarding IL-6 and
IL-10 bioactivity or mRNA levels in BAL cells from RAO
horses after challenge. However, these results may be due
to differences in sampling time or the type of inhalation
provocation [20,21]. Regarding IL-10, others have shown
that inhalation challenge with lipopolysaccharide (LPS)
elevates IL-10 mRNA expression in both BAL alveolar
macrophages [20] and peripheral blood cells in RAO-sus-
ceptible horses [22]. However inhalation challenge with
other agents failed to induce this up-regulation in BAL
macrophages [20]. Thus it is possible that not only the
sampling time, but also the mode and individual compo-
nents of challenge agent may influence the dynamics of
cytokine regulation. In our study, the negative correlation
of bronchial TNF-α levels to IL-6 mRNA levels in controls
examined on pasture may indicate the time-dependent
changes in the expression of these two cytokines [23] or
simply be coincidental. The positive correlation of IL-10
mRNA expression with TNF-α measured by IHC (rs =
0.967, p = 0.007) may have reflected the immunoregula-
tory properties of IL-10 as a counterbalance to TNF-α [24].
There are also several other possible reasons that this
study did not detect alteration of these cytokines under
exacerbation. Firstly, the time point for sample collection
in correlation to provocation might have failed to capture
a temporally related enhancement in examined cytokine
expression. Others workers have shown time-dependent
IL-10 expression in the bronchial epithelium of an RAO  horse in exacerbation Figure 1
IL-10 expression in the bronchial epithelium of an RAO 
horse in exacerbation.
Table 1: Bronchial epithelium expression of IL-6, IL-10 and TNF-α in RAO horses on crisis and in remission, and in control horses on 
pasture.
Cytokine RAO provocation RAO pasture Controls pasture RAO, p-value provocation/pasture
IL-6 1.08 (0.83–1.64) 0.63 (0.28–1.97) 0.94 (0.57–1.18) p = 0.67, NS
IL-10 3.68 (2.46–6.11) 4.18 (2.28–5.38) 2.64 (1.77–5.95) p = 0.21, NS
TNF-α 4.18 (1.26–5.03) 1.21 (0.95–2.51) 1.18 (0.54–2.10) p = 0.45, NS
Immunohistochemical determination of percentage (%) of positively stained area of bronchial epithelium for selected cytokines. Values are given as 
medians (1st–3rd quartiles). NS = Not significant.BMC Veterinary Research 2008, 4:8 http://www.biomedcentral.com/1746-6148/4/8
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expression of inflammatory mediators in horse airways
that occur within hours or days after provocation [13-
16,18,20]. In contrast, our samples were collected only
once RAO-horses had developed clinical signs of impaired
pulmonary function, (ΔPplmax more than 1.5 kPa), rather
than at a predetermined time after provocation. Alterna-
tively, it can be questioned whether the bronchial epithe-
lial tissues obtained were representative for the study. As
shown in earlier studies in human COPD and asthma
patients, there is variability of distribution of inflamma-
tory cells in bronchial tissue which can require examina-
tion of biopsies from more than one airway generation to
increase the statistical power to detect differences between
individuals [25,26]. Of the six biopsies we obtained from
each horse, the first two were from the first generation
bronchus and examined by PCR. The remaining four
biopsies were obtained progressively more distally in the
lung and from these morphologically representative biop-
sies were then selected for further analysis by IHC. As well,
the small biopsy size, the sampling of the epithelial layer
without underlying deeper mucosa, and the fact that biop-
sies are generally sampled from more proximal airways
and from subcarinae, are additional limitations to the
sampling procedure. To secure antigen preservation and
optimal morphology for IHC studies, we chose plastic
resin embedding, GMA, used in several human studies
together with acetone fixation containing protease inhib-
itors. This embedding technique ensures both excellent
antigen preservation for IHC and morphologic overview
[11]. When planning the study, the choice of equine anti-
bodies was limited. At  present there are several equine
specific antibodies available for the  investigated
cytokines.
The primers used in PCR have been evaluated and vali-
dated in other studies. Moreover, companion studies in
these RAO subjects have shown increased expression dur-
ing crisis of other inflammatory mediators in BAL and epi-
thelial cells collected by bronchial brushings and in
biopsies [27-29], indicating ongoing inflammatory proc-
ess. Thus, our findings suggest that, within the complex
interrelation of regulatory cytokines, IL-6, IL-10 and TNF-
α may not play a key role in the inflammation in bron-
chial tissues in horses with RAO.
Apart from IL-10 for the RAO horses at pasture, the lack of
correlation of the cytokine mRNA to protein levels of IL-
6, IL-10 and TNF-α was not unexpected as regulation of
actual protein level is likely more complex than a direct
relationship to amount of mRNA and the rate of transla-
tion and thus the amount of mRNA does not necessarily
directly correlate with the level of protein expressed [30].
Conclusion
These results show that combining quantitative real-time
PCR and IHC methods on bronchial biopsy tissues can
provide a new complementary research tool to study the
role of mediators and structural elements in bronchial tis-
sue associated with the inflammatory process in RAO-
horses. Future work should focus on examining temporal
events in the early stages following challenge exposure,
and expanding the range of cytokines examined to study
the role of airway epithelial cells in the immunopathogen-
esis of RAO.
Methods
Horses
Seven RAO horses with a history of recurrent episodes of
respiratory distress when exposed to dusty stable environ-
ment (Mean weight 431 ± SD 90 kg, age 19.7 ± 6.6 years)
and 6 healthy controls (Mean weight 475 ± SD 33 kg, age
16.8 ± 7.9 years) were included in the study. The RAO
horses were sampled once clinical signs appeared follow-
ing provocation with mouldy hay and straw bedding and
secondly when in remission after two months on pasture,
during which time six healthy horses were also similarly
examined. RAO horses were sampled after provocation as
previously described [31] when pulmonary function
measurements indicated maximum change in transpul-
monary pressure (ΔPplmax) above 1.5 kPa [32]. The clini-
cal signs in horses were scored by a blinded observer
according to an earlier reported system [32]. This study
was approved by the institutional animal care and use
committee, University of Liège, Belgium.
Comparative (fold) cytokine mRNA expression Figure 2
Comparative (fold) cytokine mRNA expression. The 
relative (fold) increase of cytokine mRNA levels (IL-6, IL-10 
and TNF-α) is shown with interquartile range and line for 
median value. The horizontal line represents theoretical 
median value 1 (theoretically no difference between provoca-
tion and remission or ΔΔCT = 0,   = 20 = 1). 2
ΔΔCTBMC Veterinary Research 2008, 4:8 http://www.biomedcentral.com/1746-6148/4/8
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Pulmonary function tests
Pleural pressure changes were measured with oesophageal
balloon catheter connected to a calibrated pressure trans-
ducer and the air flow and volume measured through a
facemask by a Fleish pneumotachograph (Model NR4;
Gould Electronics, Eichstetten, Germany). The maximum
transpulmonary pressure, pulmonary resistance and
dynamic compliance were obtained from a lung function
computer (Haemodynamics Respiratory System; ACEC,
Namur, Belgium). Each measurement period averaged 2
min, and average values of 10 representative breaths were
analysed.
Bronchoalveolar lavage
After sedation with romifidine (0.01 mg/kg, iv, Sedivet;
Boehringer Ingelheim, Ingelheim, Germany) and butor-
phanol tartrate (0.02 mg/kg IV, Torbugesic; Fort Dodge,
Wyeth, Madison, New Jersey, USA) all horses had endo-
scopically (Pentax, Breda, The Netherlands, 170 cm × 12.9
mm) guided bronchial biopsy followed by BAL.
The BAL was performed with 6 × 60 ml sterile isotonic
saline solution (37°C). Fluid recovered was placed on ice,
samples pooled and aliquots collected for cytologic study.
One aliquot was used to determine total leukocyte counts
manually (THOMA cell; VWR International, Fontenay-
sous-Bois, France). Another aliquot was centrifuged at 200
× g for 15 minutes (Shandon Cytospin Centrifuge,
Thermo Electron Corporation, Pittsburgh, Pennsylvania,
USA) and stained with May-Grünwald staining. Differen-
tial cell counts were determined by counting 200 cells per
slide.
Endobronchial biopsies
Sampling
Six biopsies (approximately 1–2 mm in diameter) were
collected via endoscopy from the bronchial epithelium
from subsegmental (3rd to 4th generation bronchi) and
segmental subcarinae (1st to 2nd generation bronchi) air-
ways with biopsy forceps (reusable, 240 cm, Pentax,
KW3433S, Pentax Corporation, Tokyo, Japan). The first
two biopsies from each horse were taken at the first gener-
ation bronchus and immediately frozen in liquid nitrogen
and stored at -70°C until analysis for cytokine mRNA. The
remaining biopsies were immediately placed in chilled
acetone containing protease inhibitors for further prepa-
ration until immunostaining.
Biopsy Immunostaining
Biopsies were fixed in chilled acetone containing protease
inhibitors (20 mM iodoacetamide and 2 mM phenyl
methyl sulfonyl fluoride) at -20°C overnight. After fixa-
tion, biopsies were processed into glycolmethacrylate
(GMA) resin [31] and stored at -20°C until cutting and
immunostaining. Biopsies from all horses were processed
with appropriate polyclonal  antibodies (Table 1) in the
same batch of immunostaining. Two sections from one
biopsy with optimal morphologic structure from each
horse were cut at 2 μm thickness and placed on poly-L-
Lysine treated slides. Endogenous peroxidises were inhib-
ited using 0.1% sodium azide and 0.3% hydrogen perox-
ide for 30 minutes. After 3 × 5 minute washes in TRIS-
buffered saline with 0.1% Triton-X-100 (TBST), non-spe-
cific antibody binding was blocked with undiluted culture
medium, Dulbecco's Modified Eagle's Medium (Sigma,
Missouri, US) containing 10% fetal calf serum and 1%
bovine serum albumin (BSA) for 30 minutes. Further
blocking of non-specific antibody binding was then done
by incubation with swine normal serum for 30 minutes.
The primary antibodies IL-6, IL-10 and TNF-α; (Table 2)
diluted in 0.05% TBST with 1% BSA, were applied and
incubated overnight. After rinsing with TBST for 3x5 min-
utes, biotinylated swine anti goat IgG F(ab´)2 (Dako Glos-
trup Denmark) was applied for 2 hours, followed by the
streptavidin-biotin horseradish peroxidase complex
(Dako) for another 2  hours. The sections were then visu-
alized with diaminobenzidine (DAB) to yield a brown
colour and counter-stained with Mayer Haematoxylin.
TBST  treated biopsies were used as negative controls.
Quantification of epithelial expression of cytokines
Cytokine immunoreactivity was quantified using a colour
video camera (Sony DXC-950P – Sony, Tokyo, Japan)
containing 380,000 effective picture elements (pixels).
The camera was connected to a Leica Imaging Worksta-
tion, with specific PC software (Leica Q500IW, Leica
Cambridge UK). The image setting included a possibility
to carefully adjust the individual colour components
being displayed by the system in order to ensure a close
match between the direct image and that being displayed.
Detection of an appropriate colour was quantified using
binary definition of colour images as displayed on the
screen. The binary image required the user to define which
pixel in the image that was to be considered for measure-
ment. In short, the positively stained area was managed as
a grid of pixels containing the binary value 1 (the pixel is
"set") and remaining area contains the binary value 0 (the
pixel is not "set"). All intact epithelium from both sec-
tions was used for quantification of epithelial area, from
which positive immunoreactivity area was compared to
the total measured area.
Table 2: Polyclonal antibodies used in IHC staining of bronchial 
epithelium.
Anti-equine Dilution Source
IL-6 1: 40 R & D SYSTEM, Abingdon, UK
IL-10 1: 25 R & D SYSTEM, Abingdon, UK
TNF-α 1: 40 R & D SYSTEM, Abingdon, UKBMC Veterinary Research 2008, 4:8 http://www.biomedcentral.com/1746-6148/4/8
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Quantitative real-time PCR
The biopsies for PCR were stored at -80°C until analysis.
Isolation of total RNA from biopsies was performed with
Trizol™ (Sigma-Aldrich Corp. AB, Stockholm, Sweden)
according to the manufacturer's instructions. cDNA was
synthesized from 500 ng total RNA using gene specific
primers and Superscript III reverse transcriptase (Invitro-
gen)
Relative quantification of equine cytokine mRNA expres-
sion was performed by quantitative real-time PCR (RT-
PCR) using a 7300 Real Time System (Applied Biosys-
tem). Primer and probe sequences are listed in table 3.
The RT-PCR reaction was run with Platinum Taq polymer-
ase for 45 cycles of: 95°C, 15 s and 60°C, 1 min. All sam-
ples were run in triplicate and non template controls were
included in each run. The RNA levels of the target genes
were normalized against GAPDH RNA levels and the com-
parative CT ( ) method was used for calculating rel-
ative cytokine mRNA expression. The PCR efficiencies, as
determined by assaying serial dilutions of RNA, were
approximately equal for the target genes and the house-
keeping genes.
Statistical analyses
Statistical comparisons were performed using a commer-
cially available statistical software program (MINITAB).
Because of the low number of animals data were treated
nonparametrically. Descriptive statistics from each sam-
pling period were calculated. The Wilcoxon signed rank
test used to assess for differences between provocation
and remission in RAO-horses, using a two tailed test
(immunohistochemistry, BAL cytology, clinical score,
pulmonary function), and descriptive data for the latter
three categories presented as medians ± SD. The Wilcoxon
signed rank test was also used for relative cytokine expres-
sion with PCR analysis where the theoretic median value
1 was used (theoretically no difference between provoca-
tion and remission or ΔΔCT = 0,   = 20 = 1), where
values over 1 indicate up regulation during provocation
compared to pasture. The difference between mean ΔCT
values for RAO-susceptible horses in remission and con-
trols on pasture for each cytokine was used to count differ-
ences in cytokine mRNA expression and statistically tested
using the Mann Whitney test. Spearman rank order corre-
lation was used to evaluate the correlation in cytokine
expression with PCR and IHC in biopsies and for correla-
tion between cytokine expression and cytological find-
ings. The results from BAL cell counts and pulmonary
function from controls and principal animals during pas-
ture were analysed using the Mann-Whitney test. A p-
value < 0.05 was set as the level of significance.
Authors' contributions
MR: Contributed to study design, clinical part of the study
with sample collection and laboratory work, analyzed the
data and drafted the manuscript.
AR: Performed the real-time PCR test and contributed to
the data interpretation.
J. Pourazar: Performed the immunohistochemical analy-
sis of endobronchial biopsies.
TA: Contributed to study design, coordination clinical
part of the study and manuscript drafting.
TS, PL, LC: Contributed to study design, critical evaluation
of data and manuscript drafting.
JP: Was involved in the study design and coordination,
clinical part of the study with sample collection, critical
evaluation of data and manuscript drafting.
All authors read and approved the final manuscript.
Acknowledgements
Major funding for this project was through grants from the Swedish Horse 
Racing Totalizator Board (ATG), and from FORMAS.
References
1. Knight DA, Holgate ST: The airway epithelium: structural and
functional properties in health and disease.  Respirology 2003,
8(4):432-446.
2. Takizawa H: Bronchial epithelial cells in allergic reactions.  Curr
Drug Targets Inflamm Allergy 2005, 4(3):305-311.
3. Takizawa H: Airway epithelial cells as regulators of airway
inflammation (Review).  Int J Mol Med 1998, 1(2):367-378.
2
−ΔΔCT
2
ΔΔCT
Table 3: Primer sequences and probes for real-time PCR assays.
Gene Forward primer 5' to 3' Reverse primer 5' to 3' Probe 5' to 3'
GAPDHa AAG TGG ATA TTG TCG CCA TCA AT AAC TTG CCA TGG GTG GAA TC TGA CCT CAA CTA CAT GGT CTA CAT GTT TCA
IL-6 AGC AAG TGT GAA AAC AGC AAG CAT CAG GCA GGT CTC CTG AT CTG GCA GAA AAC AAC CTG AAT CTT CCA
IL-10 TTC AGC AGG GTG AAG ACT TTC CTT GGC AAC CCA GGT AAC CCT TA TGT TGA ACG GGT CCC TGC TGG AG
TNF-α GCT CCA GAC GGT GCT TGT G GCC GAT CAC CCC AA AG TG TGT CGC AGG AGC CAC CAC GCT
Primers and Probes designed from nucleotide sequence for this study. aD.M. Ainsworth et al. Recurrent airway obstruction (RAO) in horses in 
characterised by IFN-γ and IL-8 production in bronchoalveolar lavage cells. In: Veterinary Immunology and Immunopathology 96 (2003) 83–91.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Veterinary Research 2008, 4:8 http://www.biomedcentral.com/1746-6148/4/8
Page 7 of 7
(page number not for citation purposes)
4. Holgate ST, Lackie P, Wilson S, Roche W, Davies D: Bronchial epi-
thelium as a key regulator of airway allergen sensitization
and remodeling in asthma.  Am J Respir Crit Care Med 2000, 162(3
Pt 2):S113-7.
5. Holgate ST: Inflammatory and structural changes in the air-
ways of patients with asthma.  Respir Med 2000, 94 Suppl
D:S3-6.
6. Pepe C, Foley S, Shannon J, Lemiere C, Olivenstein R, Ernst P, Ludwig
MS, Martin JG, Hamid Q: Differences in airway remodeling
between subjects with severe and moderate asthma.  J Allergy
Clin Immunol 2005, 116(3):544-549.
7. Brown JL, Behndig AF, Sekerel BE, Pourazar J, Blomberg A, Kelly FJ,
Sandstrom T, Frew AJ, Wilson SJ: Lower airways inflammation in
allergic rhinitics: a comparison with asthmatics and normal
controls.  Clin Exp Allergy 2007, 37(5):688-695.
8. Pourazar J, Mudway IS, Samet JM, Helleday R, Blomberg A, Wilson SJ,
Frew AJ, Kelly FJ, Sandstrom T: Diesel exhaust activates redox-
sensitive transcription factors and kinases in human airways.
Am J Physiol Lung Cell Mol Physiol 2005, 289(5):L724-30.
9. Wallin A, Sue-Chu M, Bjermer L, Ward J, Sandstrom T, Lindberg A,
Lundback B, Djukanovic R, Holgate S, Wilson S: Effect of inhaled
fluticasone with and without salmeterol on airway inflamma-
tion in asthma.  J Allergy Clin Immunol 2003, 112(1):72-78.
10. Fabbri LM, Durham S, Holgate ST, O'Byrne PM, Postma DS: Assess-
ment of airway inflammation: an overview.  Eur Respir J Suppl
1998, 26:6S-8S.
11. Jeffery P, Holgate S, Wenzel S: Methods for the assessment of
endobronchial biopsies in clinical research: application to
studies of pathogenesis and the effects of treatment.  Am J
Respir Crit Care Med 2003, 168(6 Pt 2):S1-17.
12. Howarth PH, Bradding P, Montefort S, Peroni D, Djukanovic R, Car-
roll MP, Holgate ST: Mucosal inflammation and asthma.  Am J
Respir Crit Care Med 1994, 150(5 Pt 2):S18-22.
13. Ainsworth DM, Grunig G, Matychak MB, Young J, Wagner B, Erb HN,
Antczak DF: Recurrent airway obstruction (RAO) in horses is
characterized by IFN-gamma and IL-8 production in bron-
choalveolar lavage cells.  Veterinary immunology and immunopathol-
ogy 2003, 96(1-2):83-91.
14. Ainsworth DM, Wagner B, Franchini M, Grunig G, Erb HN, Tan JY:
Time-dependent alterations in gene expression of inter-
leukin-8 in the bronchial epithelium of horses with recurrent
airway obstruction.  Am J Vet Res 2006, 67(4):669-677.
15. Davis MS, Malayer JR, Vandeventer L, Royer CM, McKenzie EC, Wil-
liamson KK: Cold weather exercise and airway cytokine
expression.  J Appl Physiol 2005, 98(6):2132-2136.
16. Davis MS, Williams CC, Meinkoth JH, Malayer JR, Royer CM, William-
son KK, McKenzie EC: Influx of neutrophils and persistence of
cytokine expression in airways of horses after performing
exercise while breathing cold air.  Am J Vet Res 2007,
68(2):185-189.
17. Berndt A, Derksen FJ, Venta P, Ewart S, Yuzbasiyan-Gurkan V, Rob-
inson NE: Elevated amount of toll-like receptor 4 mRNA in
bronchial epithelial cells is associated with airway inflamma-
tion in horses with Recurrent Airway Obstruction.  Am J Physiol
Lung Cell Mol Physiol 2006.
18. Debrue M, Hamilton E, Joubert P, Lajoie-Kadoch S, Lavoie JP:
Chronic exacerbation of equine heaves is associated with an
increased expression of interleukin-17 mRNA in bronchoal-
veolar lavage cells.  Veterinary immunology and immunopathology
2005, 105(1-2):25-31.
19. Gerber V, Robinson NE, Venta RJ, Rawson J, Jefcoat AM, Hotchkiss
JA: Mucin genes in horse airways: MUC5AC, but not MUC2,
may play a role in recurrent airway obstruction.  Equine Vet J
2003, 35(3):252-257.
20. Laan TT, Bull S, Pirie R, Fink-Gremmels J: The role of alveolar
macrophages in the pathogenesis of recurrent airway
obstruction in horses.  J Vet Intern Med 2006, 20(1):167-174.
21. Giguere S, Viel L, Lee E, MacKay RJ, Hernandez J, Franchini M:
Cytokine induction in pulmonary airways of horses with
heaves and effect of therapy with inhaled fluticasone propi-
onate.  Veterinary immunology and immunopathology 2002, 85(3-
4):147-158.
22. van den Hoven R, Duvigneau JC, Hartl RT, Gemeiner M: Clen-
buterol affects the expression of messenger RNA for inter-
leukin 10 in peripheral leukocytes from horses challenged
intrabronchially with lipopolysaccharides.  Vet Res Commun
2006, 30(8):921-928.
23. Wang Z, Malmberg P, Larsson P, Larsson BM, Larsson K: Time
course of interleukin-6 and tumor necrosis factor-alpha
increase in serum following inhalation of swine dust.  Am J
Respir Crit Care Med 1996, 153(1):147-152.
24. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE:
Interleukin 10(IL-10) inhibits cytokine synthesis by human
monocytes: an autoregulatory role of IL-10 produced by
monocytes.  J Exp Med 1991, 174(5):1209-1220.
25. Gamble E, Qiu Y, Wang D, Zhu J, Vignola AM, Kroegel C, Morell F,
Hansel TT, Pavord ID, Rabe KF, Barnes NC, Jeffery PK: Variability
of bronchial inflammation in chronic obstructive pulmonary
disease: implications for study design.  Eur Respir J 2006,
27(2):293-299.
26. Haley KJ, Sunday ME, Wiggs BR, Kozakewich HP, Reilly JJ, Mentzer SJ,
Sugarbaker DJ, Doerschuk CM, Drazen JM: Inflammatory cell dis-
tribution within and along asthmatic airways.  Am J Respir Crit
Care Med 1998, 158(2):565-572.
27. Art T, Franck T, Lekeux P, de Moffarts B, Couetil L, Becker M,
Kohnen S, Deby-Dupont G, Serteyn D: Myeloperoxidase concen-
tration in bronchoalveolar lavage fluid from healthy horses
and those with recurrent airway obstruction.  Can J Vet Res
2006, 70(4):291-296.
28. Couetil LL, Art T, de Moffarts B, Becker M, Melotte D, Jaspar F,
Bureau F, Lekeux P: DNA binding activity of transcription fac-
tors in bronchial cells of horses with recurrent airway
obstruction.  Veterinary immunology and immunopathology 2006,
113(1-2):11-20.
29. Riihimaki M, Raine A, Art T, Lekeux P, Couetil L, Pringle J: Partial
divergence of cytokine mRNA expression in bronchial tis-
sues compared to bronchoalveolar lavage cells in horses with
recurrent airway obstruction.  Veterinary immunology and immun-
opathology 2007.
30. You L, Yin J: Patterns of regulation from mRNA and protein
time series.  Metab Eng 2000, 2(3):210-217.
31. Britten KM, Howarth PH, Roche WR: Immunohistochemistry on
resin sections: a comparison of resin embedding techniques
for small mucosal biopsies.  Biotech Histochem 1993,
68(5):271-280.
32. Couetil LL, Art T, de Moffarts B, Becker M, Melotte D, Jaspar F,
Bureau F, Lekeux P: Effect of beclomethasone dipropionate and
dexamethasone isonicotinate on lung function, bronchoalve-
olar lavage fluid cytology, and transcription factor expres-
sion in airways of horses with recurrent airway obstruction.
J Vet Intern Med 2006, 20(2):399-406.